Kent's wellness culture drives strong interest in GLP-1 treatments. Mounjaro® is the FDA-approved Injectable pen Tirzepatide product manufactured by Eli Lilly. Weight Method offers a separate program for Kent residents: licensed Washington providers evaluate eligible patients via telehealth and prescribe compounded Tirzepatide, dispensed by a U.S.-licensed 503A pharmacy. Compounded Tirzepatide is not FDA-approved. The Weight Method program starts at $329/month, with the provider evaluation, the medication, ongoing care, and home delivery to Kent included.
GLP-1 treatment prescribed by licensed providers. Delivered to your door.
Free consultation · No commitment · Results in weeks
From 2,000+ patients · Kent is already seeing results
GLP-1 weight-loss treatment available to eligible patients in Kent, WA. Weight Method offers compounded tirzepatide, prescribed by licensed providers, from $329/month with virtual consultations and direct-to-door shipping.
For many people in Kent, diet and exercise alone have not produced lasting results — and that is not a failure of willpower. Tirzepatide addresses hormonal drivers involved in body weight regulation. Mounjaro® is the FDA-approved Injectable pen Tirzepatide product by Eli Lilly, approved in 2022 for Type 2 diabetes. Weight Method offers a separate telehealth program: licensed providers evaluate eligible patients and prescribe compounded Tirzepatide, dispensed by a U.S.-licensed 503A pharmacy. Compounded Tirzepatide is not FDA-approved. The program is priced at $329/month, including the evaluation, the medication, ongoing care, and home delivery to Kent.
Urban residents in Kent are often surrounded by healthcare options yet still struggle to access GLP-1 treatment. Primary care physicians may not specialize in GLP-1 prescribing, and specialist clinics charge $500+ per visit. Weight Method's all-inclusive compounded Tirzepatide program — consultation, medication, and ongoing support at $329/month — is built for the urban patient who values quality and efficiency. Compounded Tirzepatide is dispensed by a U.S.-licensed 503A pharmacy and is not FDA-approved.
Compounded GLP-1 medications dispensed by U.S.-licensed 503A pharmacies.

Compounded semaglutide. Once-weekly subcutaneous injection.

Compounded tirzepatide. Dual-action GLP-1/GIP, once-weekly subcutaneous injection.
Consult with a licensed provider in Washington and start Mounjaro from $329/month.
Get Started NowFree consultation. No commitment.